Inactief instrument

Andere talen Biotech Acquisition Company Nasdaq

Aandelen

BIOTU

KYG1125A1242

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

BIOTECH ACQUISITION CO : Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	02-02-23
Biotech Acquisition to Dissolve, Liquidate	02-02-23
Biotech Acquisition Company(NasdaqCM:BIOT) dropped from NASDAQ Composite Index	02-02-23
Biotech Acquisition Company Announces Liquidation	02-02-23
Biotech Acquisition Company Announces Liquidation	02-02-23
BIOTECH ACQUISITION CO : Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)	25-01-23
BIOTECH ACQUISITION CO : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)	11-01-23
Biotech Acquisition Says New Sponsor to Make Additional Contributions Related to Proposed Business Combination Extension	05-01-23
Biotech Acquisition Company Announces Plan for New Sponsor to Make Additional Contributions to Trust Account Upon Approval of Proposed Extension Amendment	04-01-23
BIOTECH ACQUISITION CO : Entry into a Material Definitive Agreement (form 8-K)	22-12-22
Biotech Acquisition Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-22
BIOTECH ACQUISITION CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-11-22
BIOTECH ACQUISITION CO : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	11-10-22
Biotech Acquisition Company announced that it expects to receive $0.25 million in funding	04-10-22
BIOTECH ACQUISITION CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-08-22
Blade Therapeutics to Participate in “Drug Development in Pulmonary Medicine” Panel Discussion at 2022 BTIG Biotechnology Conference	01-08-22
BIOTECH ACQUISITION CO : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	17-06-22
Biotech Acquisition : and Blade Therapeutics Mutually Agree to Terminate Business Combination Agreement - Form 8-K	13-06-22
Biotech Acquisition, Blade Therapeutics Agree to Terminate Merger Agreement	13-06-22
BIOTECH ACQUISITION CO : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	13-06-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Biotech Acquisition Company Nasdaq

Aandelen

BIOTU

KYG1125A1242

Andere talen

Filters